Federal award
SIEMENS HEALTHCARE SL.
N6817121P6122
Contract
Obligated and Ceiling
- Obligated (net)
- $117,822.92
- Ceiling (potential value, not spending)
- $117,822.92
- Current value
- $117,822.92
- Gross positive obligations
- $118,351.85
Obligated is what the government has committed, net of de-obligations. The ceiling is the most the award or vehicle could ever reach; it is shown separately and never added to, or compared as, spending.
Award Details
- Recipient
- SIEMENS HEALTHCARE SL. · J5YJEL7TYQ81
- Owner company
- Not a reviewed companyNo reviewed company owns this recipient.
- Reported parent
- SIEMENS AKTIENGESELLSCHAFT · RDB2AM2GGHH8
- Awarding agency
- Department of War · sub-agency 1700 · office N68171
- Funding agency
- Department of War · sub-agency 97DH
- Product or service (PSC)
- 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS
- Industry (NAICS)
- 325413 · IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING
- PIID
- N6817121P6122
- Award type code
- B
- Actions
- 7 · Sep 27, 2021 to Sep 16, 2025
- Why it is listed
- gross positive obligations of $100k or more (contracts)
Action History7
| Date | FY | Mod | Action type | Obligation | Company in company totals |
|---|---|---|---|---|---|
| Sep 16, 2025 | FY2025 | P00006 | G | $25,385.85 | — |
| Sep 18, 2024 | FY2024 | P00005 | G | $20,072.06 | — |
| Sep 25, 2023 | FY2023 | P00004 | G | $24,844.12 | — |
| Mar 6, 2023 | FY2023 | P00003 | M | −$528.93 | — |
| Nov 25, 2022 | FY2023 | P00002 | B | $5,006.94 | — |
| Aug 19, 2022 | FY2022 | P00001 | G | $21,856.17 | — |
| Sep 27, 2021 | FY2021 | 0 | — | $21,186.71 | — |
Newest first. Every obligation is shown as reported, including zero and negative (de-obligation) actions. Award lists belong to the company of the latest action; company totals credit each action to the company named on that row, so a note marks rows where the two differ.